Desk›Healthcare› Artemis Medicare Services Ltd
Artemis Medicare Services Ltd
BSE 542919 · NSE ARTEMISMED · ISIN INE025R01021 · Group B · Active
Healthcare › Healthcare › Healthcare Services › Hospital
₹319.30
+0.73%
BSE close, 28 August 2026
₹5,053.68 cr
15.8 cr shares · Small cap
₹1,565.90 cr
as published
44.7× · 6.35×
EPS ₹7.14 · BV ₹50.28
1,060.49 / 103.44
₹ cr, as filed
26
8 selected · 31%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -4.4% |
|---|---|
| Against 52-week low | +57.4% |
| Day change | +0.73% |
| Size band | Small cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹7.14 |
|---|---|
| Price / earnings | 44.72× |
| Price / book | 6.35× |
| Book value — derived, price ÷ P/B | ₹50.28 |
| Return on equity | 14.20% |
| Operating margin | 21.59% |
| Net margin | 11.01% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 14.20%
- ROE as published
- 14.20%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 282.01 | 31.05 | 1.96 | 21.59% | 11.01% |
| Mar-26 · Q | 273.79 | 29.55 | 1.87 | 21.17% | 10.79% |
| FY25-26 | 1,060.49 | 103.44 | 6.55 | 19.99% | 9.75% |
Quarter on quarter
- Revenue, quarter on quarter
- +3.0%
- Net profit, quarter on quarter
- +5.1%
- Operating margin, quarter on quarter
- +42 bps
Disclosure profile 26 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Change in Directorate | 2 |
| Board Outcome | 1 |
| Concall Transcript | 1 |
| Credit Rating | 1 |
| Investor Presentation | 1 |
| Press Release | 1 |
| Results | 1 |
| Selected sub-total | 8 |
| Procedural | |
| Analyst / Investor Meet | 5 |
| General | 3 |
| AGM / EGM | 2 |
| Newspaper Publication | 2 |
| Auditor Appointment | 1 |
| Board Meeting | 1 |
| Compliance Certificate | 1 |
| Monitoring Agency | 1 |
| Postal Ballot | 1 |
| Trading Window | 1 |
| Procedural sub-total | 18 |
| Total | 26 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
26 filings · 8 selected · busiest 2026-08-03
Filing rhythm · the twelve most recent
2026-08-042026-10-06
SelectedProcedural
Filings
26 in the window · 17 earlier on record
-
6 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Reg. 74(5) of SEBI (DP) Regulations for the quarter ended September 30, 2026
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
29 September 2026 ·
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Disclosure under Regulation 30 of the SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Company Update / General View filing →
-
29 September 2026 ·
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Company Update / General View filing →
-
28 September 2026 ·
Closure of Trading Window
Notice of closure of Trading Window for the quarter ending September 30, 2026
Insider Trading / SAST / Closure of Trading Window View filing →
-
24 September 2026 ·
Credit Rating
Intimation regarding reaffirmation of Credit Rating
Company Update / Credit Rating View filing →
-
15 September 2026 ·
Newspaper Publication
Newspaper Publication for opening of the special window for transfer and dematerialisation of physical securities
Company Update / Newspaper Publication View filing →
-
8 September 2026 ·
Analyst / Investor Meet - Intimation
Analysts/ Institutional Investors' Conference - September 22, 2026
Company Update / Analyst / Investor Meet View filing →
-
27 August 2026 ·
Analyst / Investor Meet - Intimation
Analysts/ Institutional Investors' Conference - September 3, 2026
Company Update / Analyst / Investor Meet View filing →
-
10 August 2026 ·
Earnings Call Transcript
Transcript of Earnings Conference Call - Q1 FY27
Company Update / Earnings Call Transcript View filing →
-
10 August 2026 ·
Analyst / Investor Meet - Intimation
Analysts/ Institutional Investors' Conference - August 13, 2026
Company Update / Analyst / Investor Meet View filing →
-
4 August 2026 ·
Analyst / Investor Meet - Outcome
Audio Recording of Earnings Conference Call - Q1 FY27
Company Update / Analyst / Investor Meet View filing →
-
4 August 2026 ·
Newspaper Publication
Newspaper Publication - August 4, 2026
Company Update / Newspaper Publication View filing →
-
3 August 2026 ·
Monitoring Agency Report
Monitoring Agency Report for the quarter ended June 30, 2026
Company Update / Monitoring Agency Report View filing →
-
3 August 2026 ·
Press Release / Media Release
Press Release - August 3, 2026
Company Update / Press Release / Media Release View filing →
-
3 August 2026 ·
Investor Presentation
Earnings Presentation-Q1 FY27
Company Update / Investor Presentation View filing →
-
3 August 2026 ·
Announcement Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Intimation of proposed capacity expansion by adding 200+ beds through Tower IV in the Company's flagship Hospital located at Sector-51, Gurugram
Company Update / General View filing →
-
3 August 2026 ·
Un-Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended June 30, 2026
Un-audited Financial Results (Standalone and Consolidated) of the Company for the Quarter ended June 30, 2026
Result / Financial Results View filing →
-
3 August 2026 ·
Board Meeting Outcome for Board Meeting Held On August 3, 2026
Outcome of Board Meeting held on August 3, 2026
Board Meeting / Outcome of Board Meeting View filing →
-
3 August 2026 ·
Change in Directorate
Intimation regarding completion of tenure of an Independent Director
Company Update / Change in Directorate View filing →
-
31 July 2026 ·
Appointment of Statutory Auditor/s
Re-appointment of Statutory Auditors
Company Update / Appointment of Statutory Auditor/s View filing →
-
31 July 2026 ·
Change in Directorate
Appointment of an Independent Director for a term of 3 (three) years effective from August 1, 2026
Company Update / Change in Directorate View filing →
-
31 July 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Voting Results of 22nd Annual General Meeting and Scrutinizer's Report
AGM/EGM / AGM View filing →
-
31 July 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of the 22nd Annual General Meeting held on July 31, 2026
AGM/EGM / AGM View filing →
-
29 July 2026 ·
Analyst / Investor Meet - Intimation
Intimation of schedule of Earnings Conference Call - Q1 FY27
Company Update / Analyst / Investor Meet View filing →
-
29 July 2026 ·
Board Meeting Intimation for Consideration Of Un-Audited Financial Results
Artemis Medicare Services Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/08/2026 ,inter alia, to consider and approve the Un-audited Financial ....
Board Meeting / Board Meeting View filing →
-
20 July 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Voting Results of Postal Ballot and Scrutinizer's Report
AGM/EGM / Postal Ballot View filing →
RSS feed for Artemis Medicare Services Ltd · the 50 most recent filings